Strategically and Financially Compelling Transaction
- Expands opportunities for Owens & Minor's owned-brand product portfolio - S&IP's differentiated product portfolio, which holds leading U.S. market positions and has strong brand recognition across developed markets, complements Owens & Minor's existing portfolio of brands and is expected to drive growth in revenue, operating earnings, earnings per share and cash flow.
- Accelerates Owens & Minor's strategy to deliver value at the point of care - The transaction complements Owens & Minor's business model with expanded solutions and trusted products at the point of care in the acute care and non-acute care markets.
- Creates a platform for future growth - The acquisition allows Owens & Minor to respond more quickly to a changing healthcare industry, with a focus on new opportunities for unique product solutions and value-enhancing bundles and expansion into more clinically relevant areas. The transaction also adds new skill sets, resources, and capabilities to support growth initiatives.